Skip to main content

Table 1 Patient characteristics

From: Characteristics of immunoglobulin G4-related aortitis/periaortitis and periarteritis on fluorodeoxyglucose positron emission tomography/computed tomography co-registered with contrast-enhanced computed tomography

No. Age (y) Sex Diagnostic criteria Positive histopathological site Interval between CECT and FDG-PET/CT(d) Serum IgG4 value (mg/dL) Vascular involvement Other positive site
1 79 F Definite Pancreas 38 N/A + LN, SG, P
2 75 M Definite Minor salivary gland 7 953 + LN
3 61 M Definite Minor salivary gland, bile duct 7 968 + LN
4 70 M Definite Gall bladder 9 802 + LN, P
5 67 M Definite Nasal mucosa 1 1390 + LN, SG, C
6 73 M Definite Bile duct 17 1370 + LN, SG, C, P
7 74 M Definite Lung 21 384 + LN, SG, C
8 61 F Definite Pancreas 12 149 + LN, SG, P
9 71 M Definite 43 N/A + LN, P
10 77 M Definite 6 N/A + LN
11 69 M Definite 6 733 + LN, SG
12 71 M Definite 8 469 + LN, SG, P
13 68 F Definite 13 571 + LN, P
14 68 M Definite 28 877 + LN, SG, C, P
15 58 M Definite 12 326 + LN, SG, P
16 78 M Definite Abdominal aorta 3 225 P
17 77 M Definite Bile duct 8 89.8 LN, P
18 54 M Definite Nasal mucosa, bile duct 6 455 LN, SG, P
19 73 F Definite Lacrimal gland 28 N/A LN
20 55 F Definite Minor salivary gland 80 N/A SG
21 60 F Definite Nasal mucosa 26 N/A LN, SG
22 78 M Definite Minor salivary gland, nasal mucosa 11 888 LN, SG
23 50 M Definite Nasal mucosa 5 408 LN, P
24 67 M Definite Nasal mucosa 13 377 a
25 51 F Definite Lacrimal gland 1 398 LN, SG
26 45 M Definite Submandibular gland 20 N/A LN, C
27 83 M Definite Minor salivary gland 49 905 LN, SG
28 78 F Definite Pancreas 31 243 LN, P
29 39 F Definite Lymph node 3 479 LN, SG
30 75 M Definite 88 N/A b
31 73 F Definite 56 N/A LN, SG
32 66 M Definite 32 N/A C
33 59 F Definite 8 N/A LN, SG, C, P
34 67 M Definite 33 526 C, P
35 60 M Definite 23 862 LN, SG
36 46 F Definite 30 797 LN, SG
37 58 F Definite 60 977 LN, SG
  1. Y year, d days, M male, F female, + positive, − negative, N/A not available, LN lymph node, SG salivary gland, C chest (pleura/paravertebra), P pancreas
  2. a(Patient no. 24) A patient with small hypovascular lesions in the bilateral kidney on CECT; the FDG-PET/CT findings could not be assessed due to physiological uptake by the renal parenchyma. This patient was treated for IgG4-RD
  3. b(Patient no. 30) A patient with abnormal pancreas findings on CECT, without significant abnormal FDG uptake. The patient was diagnosed as having autoimmune pancreatitis using endoscopic retrograde cholangiopancreatography